Reporting data from meta-analysis: snapshot of a moving target
- PMID: 34725703
- PMCID: PMC9022780
- DOI: 10.1093/eurheartj/ehab681
Reporting data from meta-analysis: snapshot of a moving target
Comment in
-
Strengths and limitations of meta-analyses.Eur Heart J. 2022 Feb 12;43(7):698. doi: 10.1093/eurheartj/ehab682. Eur Heart J. 2022. PMID: 34725679 Free PMC article. No abstract available.
Comment on
-
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.Eur Heart J. 2021 Jul 15;42(27):2643-2654. doi: 10.1093/eurheartj/ehab280. Eur Heart J. 2021. PMID: 34002202 Free PMC article.
-
Meta-analyses of moving targets.Eur Heart J. 2021 Jul 15;42(27):2655-2656. doi: 10.1093/eurheartj/ehab359. Eur Heart J. 2021. PMID: 34115845 Free PMC article. No abstract available.
References
-
- Pilgrim T, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Losdat S, Eeckhout E, Valgimigli M, Jüni P, Windecker S, Iglesias JF. Biodegradable- versus durable-polymer drug-eluting stents for STEMI: final 2-year outcomes of the BIOSTEMI trial. JACC Cardiovasc Interv 2021;14:639–648. - PubMed
-
- Gao C, Kogame N, Sharif F, Smits PC, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Zaman A, de Winter RJ, Onuma Y, Serruys PW. Prospective multicenter randomized all-comers trial to assess the safety and effectiveness of the ultra-thin strut sirolimus-eluting coronary stent supraflex: two-year outcomes of the TALENT trial. Circ Cardiovasc Interv 2021;14:e010312. - PubMed
-
- Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, Shahim B, Leon MB, Bangalore S, Stone GW, Ahmad Y. Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 2021;42:2643–2654. - PMC - PubMed
